**About the Editor**

#### **Angela Stefanachi**

Angela Stefanachi graduated in 1998 summa cum laude in Chemistry and Pharmaceutical Technology at the University of Bari and, after two years as postgraduate fellow, in 2000 she started her Ph.D. studies and received the Ph.D. in Medicinal Chemistry in 2004. She worked as Post-doc in the Department of Pharmaceutical Chemistry at the University of Bari from March 2004 to November 2008. In February 2009, she became Assistant Professor at the University of Bari in the Faculty of Pharmacy. She had two wide experiences as visiting scientist abroad: the first in the group of prof Enrique Ravina (Universidad de Santiago de Compostela, Spain) and the second in the group of prof. Steven Ley (University of Cambridge, UK). From March 2022, she has been associate professor at the department of pharmacy- druf sciences. Her research on the design and synthesis of small molecule through parallel organic synthesis, both on solid phase and in solution, with potential pharmacological activity toward pathologies such as cancer (CB2 Ligands, Aromatase, Protein Kinases, MDR and HDAC inhibitors), neurodegenerative diseases (AChE-BChE and Aβ1-40 aggregation inhibitors), and asthma (selective Adenosine2B receptor antagonists).

*Article*
